Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Intraoperative Drug Combination Reduces Kidney Injury in Septic Shock Surgery

By HospiMedica International staff writers
Posted on 28 Oct 2026

Septic shock is a life-threatening response to infection that can cause circulatory failure and organ injury, with global mortality rates reaching 50%. More...

Although emergency surgery can clear the underlying infection, inflammation and surgical trauma may continue to threaten kidney function. New findings suggest that adjusting drug therapy during surgery may help reduce this risk by lowering the incidence of acute kidney injury in these high-risk patients

Scientists from the University of Southampton and Zhejiang University School of Medicine evaluated the combined use of dobutamine and norepinephrine during surgery in patients with septic shock. Norepinephrine supports blood pressure, while dobutamine is a heart medication that improves blood flow. By combining these effects, the approach aims to support circulation and reduce the risk of inadequate blood supply to the kidneys.

The trial followed 584 adult patients undergoing surgery across 39 hospitals in China. Half of the patients received an infusion of dobutamine with norepinephrine. The comparison group received norepinephrine alone. The findings were published in JAMA under the title “Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative Acute Kidney Injury in Septic Shock.”

Fewer than one-quarter of patients who received the drug combination developed new or worsening kidney injury within one week after surgery. In the norepinephrine-only group, the rate was around 35%. The combination was also associated with more frequent temporary tachycardia, which affected 41% of patients compared with about 30% in the standard care group. Researchers reported no increase in serious complications such as cardiac arrest or arrhythmias.

The investigators also reported that the therapy appeared most effective against more serious kidney injury. Moderate to severe kidney injuries were roughly halved among patients who received both drugs. These patients also produced more urine immediately and showed milder overall signs of organ strain during the first day in intensive care.

“Our trial discovered that adding these two heart medications during the operation safely boosts blood flow. It also significantly cuts the risk of severe kidney damage, offering a safer way to protect vulnerable patients during high-risk surgery,” said Dr. Nazrul Islam from Southampton, senior co-corresponding author.

“Our research is timely as the International Guidelines for Management of Sepsis and Septic Shock recently said there was insufficient data to make a recommendation for the use of dobutamine. Clearly this can now be changed—and we hope our findings can help doctors rethink how they care for patients during high-risk emergency surgery,” said Dr. Xiangming Fang, primary corresponding author from Zhejiang University School of Medicine.

Related Links
University of Southampton
Zhejiang University School of Medicine


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.